These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Caforio AL; Goldman JH; Haven AJ; Baig KM; McKenna WJ Int J Cardiol; 1996 May; 54(2):157-63. PubMed ID: 8803680 [TBL] [Abstract][Full Text] [Related]
7. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Caforio AL; Mahon NJ; Mckenna WJ Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778 [TBL] [Abstract][Full Text] [Related]
8. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy. Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945 [TBL] [Abstract][Full Text] [Related]
9. Autoimmunity against M₂muscarinic acetylcholine receptor induces myocarditis and leads to a dilated cardiomyopathy-like phenotype. Yoshizawa A; Nagai S; Baba Y; Yamada T; Matsui M; Tanaka H; Miyoshi S; Amagai M; Yoshikawa T; Fukuda K; Ogawa S; Koyasu S Eur J Immunol; 2012 May; 42(5):1152-63. PubMed ID: 22328321 [TBL] [Abstract][Full Text] [Related]
12. The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies. Nussinovitch U; Shoenfeld Y Clin Rev Allergy Immunol; 2012 Jun; 42(3):298-308. PubMed ID: 21207192 [TBL] [Abstract][Full Text] [Related]
13. Antigen-specific effects of autoantibodies against sarcolemmal Na-K-ATPase pump in immunized cardiomyopathic rabbits. Baba A; Yoshikawa T; Iwata M; Anzai T; Nakamura I; Wainai Y; Ogawa S; Fu M Int J Cardiol; 2006 Sep; 112(1):15-20. PubMed ID: 16863664 [TBL] [Abstract][Full Text] [Related]
14. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy]. Lauer B; Padberg K; Schultheiss HP; Strauer BE Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303 [TBL] [Abstract][Full Text] [Related]
15. The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy. Schwimmbeck PL; Bland NK; Schultheiss HP; Strauer BE Eur Heart J; 1991 Aug; 12 Suppl D():76-80. PubMed ID: 1717275 [TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies against the beta 1-adrenergic receptor in myocarditis and dilated cardiomyopathy: localization of two epitopes]. Wallukat G; Morwinski R; Magnusson Y; Hoebeke J; Wollenberger A Z Kardiol; 1992; 81 Suppl 4():79-83. PubMed ID: 1283934 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function. Schulze K; Becker BF; Schauer R; Schultheiss HP Circulation; 1990 Mar; 81(3):959-69. PubMed ID: 2155073 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization. Wallukat G; Morwinski M; Kowal K; Förster A; Boewer V; Wollenberger A Eur Heart J; 1991 Aug; 12 Suppl D():178-81. PubMed ID: 1717272 [TBL] [Abstract][Full Text] [Related]
20. The significance of autoimmunity in myocarditis. Rose NR Ernst Schering Res Found Workshop; 2006; (55):141-54. PubMed ID: 16331858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]